Qiagen Stock Gains As Non COVID Sales Boosts Q2 Topline, Bottom-line
Qiagen N.V. (NYSE:QGEN) reported after the close of the market Thursday that its second-quarter revenues jumped 28% Y/Y as growth in…
AbbVie Q2 Earnings Beats Consensus Slightly; Guides FY21 EPS Below Consensus
AbbVie Inc (NYSE:ABBV) reports Q2 adjusted EPS of $3.11, marginally beating the consensus of $3.09. Overall sales increased 33.9% Y/Y…
Edwards Lifesciences Beats Q2 Earnings On Demand Recovery, Boosts FY2021 Guidance; Analysts Raise Price Target
Edwards Lifesciences (NYSE:EW), a cardio device company, reported Q2 earnings of $489.5 million, or $0.64, ahead of the consensus of…
Moog Sees FY 21 EPS $4.85-$5.15 vs $5.08 Est., Sales $2.82B vs $2.85B Est.
Fiscal 2021 Outlook
The Company updated its fiscal 2021 projections of 90 days ago.
Forecast sales of $2.82 billion;
Forecast diluted earnings per share of $5.00, plus or minus $0.15;
Forecast
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 29)
VF Q1 Adj. EPS $0.27 Beats $0.10 Estimate, Sales $2.19B Beat $2.14B Estimate’; Raises Guidance
VF (NYSE:VFC) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.10 by 170 percent. This is a 147.37 percent increase over losses of $(0.57) per share from the same period last
Johnson Controls Intl Q3 EPS $0.83, Inline, Sales $6.34B Beat $6.24B Estimate; Raises Guidance
Johnson Controls Intl (NYSE:JCI) reported quarterly earnings of $0.83 per share which met the analyst consensus estimate. This is a 23.88 percent increase over earnings of $0.67 per share from the same period last year.
Avient Q2 EPS $0.87 Beats $0.80 Estimate, Sales $1.24B Beat $1.11B Estimate; Raises Guidance
Avient (NYSE:AVNT) reported quarterly earnings of $0.87 per share which beat the analyst consensus estimate of $0.80 by 8.75 percent. This is a 210.71 percent increase over earnings of $0.28 per share from the same